Common Contracts
2 similar Underwriting Agreement contracts by ReneSola LTD
9,000,000 American Depositary Shares representing 18,000,000 Shares of no par value ReneSola Ltd UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2008 • ReneSola LTD • Semiconductors & related devices • New York
ReneSola Ltd, a company incorporated in the British Virgin Islands limited by shares (“Company”), proposes to issue and sell to the several Underwriters named in Schedule A hereto (“Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,149,437 American Depositary Shares (“ADSs”), each representing two of the Company’s shares of no par value (“Shares”), and the shareholders listed in Schedule B hereto (“Selling Shareholders”) propose severally to sell to the Underwriters an aggregate of 850,563 ADSs (together with the ADSs being sold by the Company, “Firm ADSs”). The respective amounts of the Firm ADSs to be so purchased by the several Underwriters are set forth opposite their names in Schedule A hereto, and the respective amounts of Firm ADSs and Option ADSs (as defined below) to be sold by the Selling Shareholders are set forth opposite to the names in Schedule B hereto. The Company and the Selling Shareholders propose to sell at the Und
10,000,000 American Depositary Shares representing 20,000,000 Shares of no par value ReneSola Ltd UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2008 • ReneSola LTD • Semiconductors & related devices • New York
ReneSola Ltd, a company incorporated in the British Virgin Islands limited by shares (“Company”), proposes to issue and sell to the several Underwriters named in Schedule A hereto (“Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 9,212,500 American Depositary Shares (“ADSs”), each representing two of the Company’s shares of no par value (“Shares”), and the shareholders listed in Schedule B hereto (“Selling Shareholders”) propose severally to sell to the Underwriters an aggregate of 787,500 ADSs (together with the ADSs being sold by the Company, “Firm ADSs”). The respective amounts of the Firm ADSs to be so purchased by the several Underwriters are set forth opposite their names in Schedule A hereto, and the respective amounts of Firm ADSs and Option ADSs (as defined below) to be sold by the Selling Shareholders are set forth opposite to the names in Schedule B hereto. The Company and the Selling Shareholders propose to sell at the Und
